{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:08:44Z","timestamp":1787314124809,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/mpa.0b013e3182550d77","type":"journal-article","created":{"date-parts":[[2012,6,14]],"date-time":"2012-06-14T07:57:29Z","timestamp":1339660649000},"page":"11-19","source":"Crossref","is-referenced-by-count":101,"title":["Utility of Contrast-Enhanced FDG-PET\/CT in the Clinical Management of Pancreatic Cancer"],"prefix":"10.1097","volume":"42","author":[{"given":"Akinori","family":"Asagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichirou","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Tanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seijin","family":"Nadano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Teramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhide","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruo","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210212","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":". Cancer statistics, 2010.","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"R2-3-20210212","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jjco\/hyp106","article-title":". Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project.","volume":"39","author":"Matsuda","year":"2009","journal-title":"Jpn J Clin Oncol"},{"key":"R3-3-20210212","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"3rd, Moore MJ, Andersen J, et al.. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"R4-3-20210212","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00280-007-0514-8","article-title":". A late phase II study of S-1 for metastatic pancreatic cancer.","volume":"61","author":"Okusaka","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"R5-3-20210212","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.crad.2003.07.002","article-title":"Imaging of pancreatic adenocarcinoma with emphasis on multidetector CT.","volume":"59","author":"Smith","year":"2004","journal-title":"Clin Radiol"},{"key":"R6-3-20210212","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1259\/bjr\/18454286","article-title":"The contribution of PETCT to improved patient management.","volume":"79","author":"Ell","year":"2006","journal-title":"Br J Radiol"},{"key":"R7-3-20210212","first-page":"1456","article-title":"Schneider W, et al..","volume":"31","author":"Reinartz","year":"2004","journal-title":"Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PETCT Eur J Nucl Med Mol Imaging"},{"key":"R8-3-20210212","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00006676-200404000-00003","article-title":"Classification of pancreatic cancer: comparison of Japanese and UICC classifications.","volume":"28","author":"Isaji","year":"2004","journal-title":"Pancreas"},{"key":"R9-3-20210212","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s005350300058","article-title":"Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems.","volume":"38","author":"Otsuki","year":"2003","journal-title":"J Gastroenterol"},{"key":"R10-3-20210212","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00535-006-1868-0","article-title":". Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal.","volume":"41","author":"Okazaki","year":"2006","journal-title":"J Gastroenterol"},{"key":"R12-3-20210212","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":". New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R13-3-20210212","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9610(05)80406-4","article-title":"Prognostic indicators for survival after resection of pancreatic adenocarcinoma.","volume":"165","author":"Geer","year":"1993","journal-title":"Am J Surg"},{"key":"R14-3-20210212","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-129-1-199807010-00007","article-title":". Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group.","volume":"129","author":"Goldberg","year":"1998","journal-title":"Ann Intern Med"},{"key":"R15-3-20210212","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0889-8553(05)70083-2","article-title":"Diagnostic approach to pancreatic cancer.","volume":"28","author":"Barkin","year":"1999","journal-title":"Gastroenterol Clin North Am"},{"key":"R16-3-20210212","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF02988521","article-title":". Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET)usefulness and limitations in clinical reality.","volume":"17","author":"Higashi","year":"2003","journal-title":"Ann Nucl Med"},{"key":"R17-3-20210212","first-page":"678","article-title":". Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases.","volume":"24","author":"Zimny","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"R18-3-20210212","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2967\/jnumed.108.051466","article-title":". Contrast-enhanced 18F-FDG PETCT: 1-stop-shop imaging for assessing the resectability of pancreatic cancer.","volume":"49","author":"Strobel","year":"2008","journal-title":"J Nucl Med"},{"key":"R19-3-20210212","first-page":"1784","article-title":". Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.","volume":"40","author":"Delbeke","year":"1999","journal-title":"J Nucl Med"},{"key":"R20-3-20210212","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00006231-200510000-00008","article-title":". Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour.","volume":"26","author":"Nishiyama","year":"2005","journal-title":"Nucl Med Commun"},{"key":"R21-3-20210212","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/1097-0142(20001215)89:12<2547::AID-CNCR5>3.0.CO;2-V","article-title":". Delayed (18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas.","volume":"89","author":"Nakamoto","year":"2000","journal-title":"Cancer"},{"key":"R22-3-20210212","first-page":"1337","article-title":". Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in PET study.","volume":"38","author":"Higashi","year":"1997","journal-title":"J Nucl Med"},{"key":"R23-3-20210212","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00535-003-1244-2","article-title":". Role of positron emission tomography with 2-deoxy-2-18Ffluoro-D-glucose in evaluating the effects of arterial infusion chemotherapy and radiotherapy on pancreatic cancer.","volume":"39","author":"Yoshioka","year":"2004","journal-title":"J Gastroenterol"},{"key":"R24-3-20210212","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1053\/j.gastro.2005.03.035","article-title":". Surgery for pancreatic cancer: recent controversies and current practice.","volume":"128","author":"Wray","year":"2005","journal-title":"Gastroenterology"},{"key":"R25-3-20210212","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000085281","article-title":". Detection of recurrent pancreatic cancer: comparison of FDG-PET with CTMRI.","volume":"5","author":"Ruf","year":"2005","journal-title":"Pancreatology"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006676-201301000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T02:13:20Z","timestamp":1618020800000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006676-201301000-00003"}},"subtitle":["Impact on Diagnosis, Staging, Evaluation of Treatment Response, and Detection of Recurrence"],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0b013e3182550d77","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}